-
Postdoctoral Affairs, which provides a comprehensive professional development program . The Institute is located in fun, affordable and family-friendly Grand Rapids, MI. Located on the banks of the Grand River
-
, women’s health, and fundamental life science. Will conduct original and collaborative research aligned with MIT HEALS; participate in programming and community events; engage with faculty, students, and
-
), Blood Cancer Journal (2022), Cell Stem Cell (2018). The Li research program is supported by multiple NIH (R01s), American Cancer Society, The Alex’s Lemonade Stand Foundation and several other prestigious
-
comprehensive care to patients of all backgrounds, and design programs to promote public health particularly among high-risk and underserved populations. We conduct groundbreaking research that advances treatment
-
to patients of all backgrounds, and design programs to promote public health particularly among high-risk and underserved populations. We conduct groundbreaking research that advances treatment, we educate
-
compassionate and comprehensive care to patients of all backgrounds, and design programs to promote public health particularly among high-risk and underserved populations. We conduct groundbreaking research
-
, diverse, and equitable environment where we provide compassionate and comprehensive care to patients of all backgrounds, and design programs to promote public health particularly among high-risk and
-
possible. We strive to ensure the diversity of our candidates, and we reflect this ethos in the way we promote the ICRF programme and in our recruitment and selection process. Imperial’s diversity networks
-
clear data presentation, ability to work efficiently in a team and with collaborators Experience in Single Cell Multi-omics techniques and multiple component analysis programs is an advantage Previous
-
integrative therapy approaches. As a successful candidate you will: Devise, plan, document, and advance basic science and translational projects in genetics, epigenetics, and precision oncology